Ahadi M, Naseh V, Salehipour M (2017) The HER-2 as a target gene of Curcumin to protect hepatocytes against the arsenic-induced carcinoma in mice. Iran J Pathol 12(2):158

PubMed  PubMed Central  Google Scholar 

Bardania H, Shojaosadati SA, Kobarfard F, Dorkoosh F (2016) Optimization of RGD-modified nano-liposomes encapsulating eptifibatide. Iran J Biotechnol 14(2):33

PubMed  PubMed Central  Google Scholar 

Bardania H, Shojaosadati SA, Kobarfard F, Morshedi D, Aliakbari F, Tahoori MT et al (2019) RGD-modified nano-liposomes encapsulated eptifibatide with proper hemocompatibility and cytotoxicity effect. Iran J Biotechnol 17(2) e2008.

Buhrmann C, Brockmueller A, Mueller A-L, Shayan P, Shakibaei M (2021) Curcumin attenuates environment-derived osteoarthritis by Sox9/NF-kB signaling axis. Int J Mol Sci 22(14):7645

CAS  PubMed  PubMed Central  Google Scholar 

Cackowski FC, Heath EI (2022) Prostate cancer dormancy and recurrence. Cancer Lett 524:103–108

CAS  PubMed  Google Scholar 

Chow SK, Chan JY, Fung K (2004) Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells. J Cell Biochem 93(1):173–187

CAS  PubMed  Google Scholar 

Fan J-X, Zeng Y-J, Wu J-W, Li Z-Q, Li Y-M, Zheng R et al (2014) Synergistic killing effect of arsenic trioxide combined with curcumin on KG1a cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 22(5):1267–1272

CAS  PubMed  Google Scholar 

Fei M, Lu M, Wang Y, Zhao Y, He S, Gao S et al (2009) Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization. Med Oncol 26(2):178–185

CAS  PubMed  Google Scholar 

Feng T, Wei Y, Lee RJ, Zhao L (2017) Liposomal curcumin and its application in cancer. Int J Nanomed 12:6027

CAS  Google Scholar 

Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A et al (2021) Epidemiology and prevention of prostate cancer. Eur Urol Oncol 4(6):877–892

Han D, Ma G, Gao Y, Su Y (2021) Curcumin synergistically enhances the cytotoxicity of arsenic trioxide in U266 cells by increasing arsenic uptake. Evidence-Based Complementary and Alternative Medicine. 2021(3083041)9. https://doi.org/10.1155/2021/3083041

Hu J, Dong Y, Ding L, Dong Y, Wu Z, Wang W et al (2019) Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment. Signal Transduct Target Ther 4(1):1–7

Google Scholar 

Huang XL, Khan MI, Wang J, Ali R, Ali SW, Kazmi A et al (2021) Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis—new insight and futuristic vision. Int J Biol Macromol 180:739–752

CAS  PubMed  Google Scholar 

Ibrahim S, Tagami T, Kishi T, Ozeki T (2018) Curcumin marinosomes as promising nano-drug delivery system for lung cancer. Int J Pharm 540(1–2):40–49

CAS  PubMed  Google Scholar 

Jiang S, Han J, Li T, Xin Z, Ma Z, Di W et al (2017) Curcumin as a potential protective compound against cardiac diseases. Pharmacol Res 119:373–383

CAS  PubMed  Google Scholar 

Jutooru I, Chadalapaka G, Sreevalsan S, Lei P, Barhoumi R, Burghardt R et al (2010) Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res 316(13):2174–2188

CAS  PubMed  PubMed Central  Google Scholar 

Khosravani F, Mir H, Mirzaei A, Kobarfard F, Bardania H, Hosseini E (2023) Arsenic trioxide and Erlotinib loaded in RGD‐modified nanoliposomes for targetedcombination delivery to PC3 and PANC‐1 cell lines. Biotechnol Appl Biochem 70(2):811–823

Large DE, Abdelmessih RG, Fink EA, Auguste DT (2021) Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev 176:113851

CAS  PubMed  Google Scholar 

Li N, Qiu S, Fang Y, Wu J, Li Q (2021) Comparison of linear vs. cyclic RGD pentapeptide interactions with integrin αvβ3 by molecular dynamics simulations. Biology 10(7):688

CAS  PubMed  PubMed Central  Google Scholar 

Liang Y, Zhao J, Zou H, Zhang J, Zhang T (2021) In vitro and in silico evaluation of EGFR targeting activities of curcumin and its derivatives. Food Funct 12(21):10667–10675

CAS  PubMed  Google Scholar 

Liu J, Liu J, Xu H, Zhang Y, Chu L, Liu Q et al (2014) Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery. Int J Nanomed 9:197–208

Google Scholar 

Liu Y, Bravo KMC, Liu J (2021a) Targeted liposomal drug delivery: a nanoscience and biophysical perspective. Nanoscale Horizons 6(2):78–94

ADS  CAS  PubMed  Google Scholar 

Liu M, Zheng B, Liu P, Zhang J, Chu X, Dong C et al (2021b) Exploration of the hepatoprotective effect and mechanism of magnesium isoglycyrrhizinate in mice with arsenic trioxide-induced acute liver injury. Mol Med Rep 23(6):1–13

Google Scholar 

Ludwig BS, Kessler H, Kossatz S, Reuning U (2021) RGD-binding integrins revisited: how recently discovered functions and novel synthetic ligands (re-) shape an ever-evolving field. Cancers 13(7):1711

CAS  PubMed  PubMed Central  Google Scholar 

Mahmoudi R, Ashraf Mirahmadi-Babaheidri S, Delaviz H, Fouani MH, Alipour M, JafariBarmak M et al (2021a) RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells. J Biomater Appl 35(7):743–753

CAS  PubMed  Google Scholar 

Mahmoudi R, Hassandokht F, Ardakani MT, Karimi B, Roustazadeh A, Tarvirdipour S et al (2021b) Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells. J Biomater Appl 35(8):1005–1018

CAS  PubMed  Google Scholar 

Margolis E, Brown G, Partin A, Carter B, McKiernan J, Tutrone R et al (2022) Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate Cancer Prostatic Dis 25(2):296–301

PubMed  Google Scholar 

Mathews V, Binu P, Paul MS, Abhilash M, Manju A, Nair RH (2012) Hepatoprotective efficacy of curcumin against arsenic trioxide toxicity. Asian Pac J Trop Biomed 2(2):S706–S711

Google Scholar 

Mehta K, Kaur B, Pandey KK, Kaler S, Dhar P (2020) Curcumin supplementation shows modulatory influence on functional and morphological features of hippocampus in mice subjected to arsenic trioxide exposure. Anat Cell Biol 53(3):355

PubMed  PubMed Central  Google Scholar 

Mirzaei A, Akbari MR, Zadeh SST, Khatami F, Mashhadi R, Aghamir SMK (2022a) Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: an in-vitro study. Tissue Cell 74:101684

CAS  PubMed  Google Scholar 

Mirzaei A, Jahanshahi F, Khatami F, Reis LO, Aghamir SMK (2022b) Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach. Tissue Cell 76:101805

CAS  PubMed  Google Scholar 

Porębska N, Poźniak M, Matynia A, Żukowska D, Zakrzewska M, Otlewski J et al (2021) Galectins as modulators of receptor tyrosine kinases signaling in health and disease. Cytokine Growth Factor Rev 60:89–106

PubMed  Google Scholar 

Qiu Y, Yin X, Li X, Wang Y, Fu Q, Huang R et al (2021) Untangling dual-targeting therapeutic mechanism of epidermal growth factor receptor (EGFR) based on reversed allosteric communication. Pharmaceutics 13(5):747

CAS  PubMed  PubMed Central  Google Scholar 

Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63

CAS  PubMed  PubMed Central  Google Scholar 

Rizvi SA, Saleh AM (2018) Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J 26(1):64–70

PubMed  Google Scholar 

Sanchez Y, Simon GP, Calvino E, de Blas E, Aller P (2010) Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. J Pharmacol Exp Ther 335(1):114–123

CAS  PubMed  Google Scholar 

Sani S, Messe M, Fuchs Q, Pierrevelcin M, Laquerriere P, Entz-Werle N et al (2021) Biological relevance of RGD-integrin subtype-specific ligands in cancer. ChemBioChem 22(7):1151–1160

CAS  PubMed  Google Scholar 

Singh SK, Singh S, Lillard JW Jr, Singh R (2017) Drug delivery approaches for breast cancer. Int J Nanomed 12:6205

CAS  Google Scholar 

Starok M, Preira P, Vayssade M, Haupt K, Salome L, Rossi C (2015) EGFR inhibition by curcumin in cancer cells: a dual mode of action. Biomacromol 16(5):1634–1642

CAS  Google Scholar 

SudheshDev S, ZainalAbidin SA, Farghadani R, Othman I, Naidu R (2021) Receptor tyrosine kinases and their signaling pathways as therapeutic targets of curcumin in cancer. Front Pharmacol 12:772510

Google Scholar 

Sun X-D, Liu X-E, Huang D-S (2012) Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. Mol Med Rep 6(6):1267–1270

CAS  PubMed  Google Scholar 

Sun M, Wang T, Li L, Li X, Zhai Y, Zhang J et al (2021) The application of inorganic nanoparticles in molecular targeted cancer therapy: EGFR targeting. Front Pharmacol 12:702445

Ulldemolins A, Seras-Franzoso J, Andrade F, Rafael D, Abasolo I, Gener P et al (2021) Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics. Cancer Drug Resist 4(1):44

CAS  PubMed  PubMed Central  Google Scholar 

Uribe ML, Marrocco I, Yarden Y (2021) EGFR in cancer: signaling mechanisms, drugs, and acquired resistance. Cancers 13(11):2748

CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Peng X, Yang D, Guo M, Xu X, Yin F et al (2022a) Bcl-2 hijacks the arsenic trioxide resistance in SH-SY5Y cells. J Cell Mol Med 26(2):563–569

CAS  PubMed  Google Scholar 

Wang L, Zhu S, Zou C, Kou H, Xu M, Li J (2022b) Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules in vitro. Heliyon 8(7):e09931

CAS  PubMed  PubMed Central  Google Scholar 

Zeng Y, Weng G, Fan J, Li Z, Wu J, Li Y et al (2016) Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep 36(3):1233–1242

CAS  PubMed  PubMed Central  Google Scholar 

Zhan Y, Chen Y, Liu R, Zhang H, Zhang Y (2014) Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling. Arch Pharmacal Res 37(8):1086–1095

CAS  Google Scholar